FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206700253> ?p ?o ?g. }

• W4206700253 abstract "Abstract Background Alzheimer’s disease (AD) is the most common form of dementia, with no effective preventative strategies or treatments. The drug development pipeline in AD has been marked by repeated failures to find an effective treatment. Increasing evidence supports the need for greater pipeline target diversity and new approaches to target the disease. The Emory‐Sage‐SGC TREAT‐AD Center (https://treatad.org) was established to forge a new path forward with the aim of developing drugs for emerging targets in AD beyond the two pathological hallmarks. By casting a wider net, we aim to develop tools and chemical probes that target the multifaceted dysregulation in the brains of AD patients, and expand the portfolio of therapeutic approaches to break the cycle of failure. We believe that this more‐inclusive perspective will enrich the AD field and advance the discovery of potential drug targets for AD. Method The Emory‐Sage‐SGC TREAT‐AD Center has selected a diverse set of novel AD targets derived from systems biology studies within the Accelerating Medicines Partnership in AD (AMP‐AD) consortium and further evaluated using data from multiple AD consortia and existing literature. Targets nominated through the AMP‐AD consortium were scored based on unbiased bioinformatic assessments across multiple lines of evidence including genetic, multi‐omic, neuropathological, and literature‐based metrics and were mapped to mechanistic hypotheses residing in distinct biological domains that are altered in AD. Target Enabling Packages, including expression constructs, knockout cell lines, assays, antibodies and crystal structures, are being generated for 20 proteins prioritized using this approach. Hit characterization and chemical probe development has started for targets in which the evidence for AD biology is strong. All data and reagents will be publicly shared through standard repositories and cataloged at the Agora site (https://agora.adknowledgeportal.org). Result The Emory‐Sage‐SGC Center goals are: to identify and prioritize novel emerging targets for AD; to generate reagents and tools for emerging targets to encourage the community to expand the pipeline of potential AD therapeutic targets; and to share all data, tools, and reagents openly, rapidly, and without restriction. Conclusion All data, protocols, reagent sets, and chemical tools and will be made widely available. For more information see www.treatad.org." @default.
• W4206700253 created "2022-01-26" @default.
• W4206700253 creator A5011122184 @default.
• W4206700253 creator A5014770642 @default.
• W4206700253 creator A5019824956 @default.
• W4206700253 creator A5021541660 @default.
• W4206700253 creator A5023920651 @default.
• W4206700253 creator A5028687972 @default.
• W4206700253 creator A5033923298 @default.
• W4206700253 creator A5038454932 @default.
• W4206700253 creator A5040860201 @default.
• W4206700253 creator A5054208950 @default.
• W4206700253 creator A5055473294 @default.
• W4206700253 creator A5060952835 @default.
• W4206700253 creator A5072454821 @default.
• W4206700253 date "2021-12-01" @default.
• W4206700253 modified "2023-09-26" @default.
• W4206700253 title "Tool and chemical probe development for emerging targets in Alzheimer’s disease: The Emory‐Sage‐SGC TREAT‐AD Center" @default.
• W4206700253 doi "https://doi.org/10.1002/alz.051447" @default.
• W4206700253 hasPublicationYear "2021" @default.
• W4206700253 type Work @default.
• W4206700253 citedByCount "0" @default.
• W4206700253 crossrefType "journal-article" @default.
• W4206700253 hasAuthorship W4206700253A5011122184 @default.
• W4206700253 hasAuthorship W4206700253A5014770642 @default.
• W4206700253 hasAuthorship W4206700253A5019824956 @default.
• W4206700253 hasAuthorship W4206700253A5021541660 @default.
• W4206700253 hasAuthorship W4206700253A5023920651 @default.
• W4206700253 hasAuthorship W4206700253A5028687972 @default.
• W4206700253 hasAuthorship W4206700253A5033923298 @default.
• W4206700253 hasAuthorship W4206700253A5038454932 @default.
• W4206700253 hasAuthorship W4206700253A5040860201 @default.
• W4206700253 hasAuthorship W4206700253A5054208950 @default.
• W4206700253 hasAuthorship W4206700253A5055473294 @default.
• W4206700253 hasAuthorship W4206700253A5060952835 @default.
• W4206700253 hasAuthorship W4206700253A5072454821 @default.
• W4206700253 hasConcept C142724271 @default.
• W4206700253 hasConcept C169760540 @default.
• W4206700253 hasConcept C2779134260 @default.
• W4206700253 hasConcept C2779483572 @default.
• W4206700253 hasConcept C2780035454 @default.
• W4206700253 hasConcept C60644358 @default.
• W4206700253 hasConcept C64903051 @default.
• W4206700253 hasConcept C70721500 @default.
• W4206700253 hasConcept C71924100 @default.
• W4206700253 hasConcept C74187038 @default.
• W4206700253 hasConcept C86803240 @default.
• W4206700253 hasConcept C98274493 @default.
• W4206700253 hasConceptScore W4206700253C142724271 @default.
• W4206700253 hasConceptScore W4206700253C169760540 @default.
• W4206700253 hasConceptScore W4206700253C2779134260 @default.
• W4206700253 hasConceptScore W4206700253C2779483572 @default.
• W4206700253 hasConceptScore W4206700253C2780035454 @default.
• W4206700253 hasConceptScore W4206700253C60644358 @default.
• W4206700253 hasConceptScore W4206700253C64903051 @default.
• W4206700253 hasConceptScore W4206700253C70721500 @default.
• W4206700253 hasConceptScore W4206700253C71924100 @default.
• W4206700253 hasConceptScore W4206700253C74187038 @default.
• W4206700253 hasConceptScore W4206700253C86803240 @default.
• W4206700253 hasConceptScore W4206700253C98274493 @default.
• W4206700253 hasIssue "S9" @default.
• W4206700253 hasLocation W42067002531 @default.
• W4206700253 hasOpenAccess W4206700253 @default.
• W4206700253 hasPrimaryLocation W42067002531 @default.
• W4206700253 hasRelatedWork W1990688647 @default.
• W4206700253 hasRelatedWork W2003060201 @default.
• W4206700253 hasRelatedWork W2032747912 @default.
• W4206700253 hasRelatedWork W2052766986 @default.
• W4206700253 hasRelatedWork W2248179576 @default.
• W4206700253 hasRelatedWork W2569242362 @default.
• W4206700253 hasRelatedWork W2921046411 @default.
• W4206700253 hasRelatedWork W2953381357 @default.
• W4206700253 hasRelatedWork W4225014330 @default.
• W4206700253 hasRelatedWork W4307501484 @default.
• W4206700253 hasVolume "17" @default.
• W4206700253 isParatext "false" @default.
• W4206700253 isRetracted "false" @default.
• W4206700253 workType "article" @default.